<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16140">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00073333</url>
  </required_header>
  <id_info>
    <org_study_id>R01MH062547</org_study_id>
    <secondary_id>R01MH062547</secondary_id>
    <nct_id>NCT00073333</nct_id>
  </id_info>
  <brief_title>Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia</brief_title>
  <official_title>Social Phobia: Assessment and Treatment of Social Skills</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Milton S. Hershey Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Milton S. Hershey Medical Center</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine whether people with social phobia are deficient in certain social
      skills.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Social phobia is a debilitating condition that can cause severe social, emotional,
      educational, and occupational functioning problems. Evidence suggests that individuals with
      social phobia are deficient in social skills, but the exact skills deficits have not been
      elucidated. This study will comprise two substudies: one will examine social skills deficits
      in social phobics and determine how they differ from those of people without social phobia;
      the other will determine if skills deficits in social phobics can be improved and whether
      improvements will affect overall social functioning.

      Participants in this study will be randomly assigned to one of three groups for 16 weeks: an
      exposure group, a social skills training and exposure (SET) group, or a wait-list control
      group. Interviews, self-reports, and simulated role plays will be used to assess the social
      skills of participants.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2002</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Social Phobia Remission</measure>
    <time_frame>Measured at Month 12</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Phobia Remission Rate at 6 Month Follow-up</measure>
    <time_frame>6 month follow up</time_frame>
    <safety_issue>No</safety_issue>
    <description>Lack of SocialPhobia Diagnosis at 6 month follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score on the SPAI</measure>
    <time_frame>Measured at Month 12</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">379</enrollment>
  <condition>Social Phobia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Social skills training and exposure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exposure treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Skills Training</intervention_name>
    <description>Social skills training once per week</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exposure Treatment</intervention_name>
    <description>Exposure once per week</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Social Phobia

        Exclusion Criteria:

          -  Axis II diagnosis of schizoid or schizotypal personality disorder or paranoia

          -  Axis II diagnosis of mental retardation, obsessive-compulsive disorder, and
             personality disorders, except for avoidant personality disorder

          -  Instability on any antidepressants

          -  Psychotic disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 1, 2013</lastchanged_date>
  <firstreceived_date>November 19, 2003</firstreceived_date>
  <firstreceived_results_date>May 14, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Milton S. Hershey Medical Center</investigator_affiliation>
    <investigator_full_name>Deborah C. Beidel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Phobic Disorders</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Phobic Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>There were two studies contained in this grant. Study 1 was an assessment study and consisted of 379 participants - 200 normal controls and 179 participants with social phobia. Study 2 was a treatment study that consisted of 106 participants with social phobia. That is the study described below.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>1Social Effectiveness Therapy</title>
          <description>Social skills training and exposure therapy - each conducted once per week. Social Skills was conducted in groups of 4-6 participants. Exposure was individual therapy conducted weekly.</description>
        </group>
        <group group_id="P2">
          <title>2Imaginal and In Vivo Exposure</title>
          <description>Exposure treatment - imaginal and in vivo exposure conducted twice per week for entire study. Imaginal was instituted first followed by in vivo exposure in the form of programmed practice</description>
        </group>
        <group group_id="P3">
          <title>3Attention Placebo</title>
          <description>Placebo - attention placebo control condition consisting of weekly telephone contact of ten minutes during which clinical status, particularly level of depression was assessed. There was no other contact</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="41"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1Social Effectiveness Therapy</title>
          <description>Social skills training and exposure therapy - each conducted once per week.</description>
        </group>
        <group group_id="B2">
          <title>2Imaginal and in Vivo Exposure</title>
          <description>Exposure treatment - imaginal and in vivo exposure conducted twice per week</description>
        </group>
        <group group_id="B3">
          <title>Attention Placebo Control</title>
          <description>Placebo - attention placebo control condition consisting of weekly telephone contact</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="46"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="106"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="45"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="105"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="36.7" spread="14.4"/>
                <measurement group_id="B2" value="36.1" spread="13.8"/>
                <measurement group_id="B3" value="36.4" spread="14.2"/>
                <measurement group_id="B4" value="36.3" spread="13.9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="25"/>
                <measurement group_id="B2" value="18"/>
                <measurement group_id="B3" value="12"/>
                <measurement group_id="B4" value="55"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="21"/>
                <measurement group_id="B2" value="23"/>
                <measurement group_id="B3" value="7"/>
                <measurement group_id="B4" value="51"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="46"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="106"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Social Phobia Remission</title>
        <time_frame>Measured at Month 12</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Score on the SPAI</title>
        <time_frame>Measured at Month 12</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Social Phobia Remission Rate at 6 Month Follow-up</title>
        <description>Lack of SocialPhobia Diagnosis at 6 month follow-up</description>
        <time_frame>6 month follow up</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Social Effectiveness Therapy</title>
            <description>Social skills training and exposure therapy - each conducted once per week.</description>
          </group>
          <group group_id="O2">
            <title>Imaginal and In Vivo Exposure</title>
            <description>Exposure treatment - imaginal and in vivo exposure conducted twice per week</description>
          </group>
          <group group_id="O3">
            <title>Attention Placebo Control</title>
            <description>Placebo - attention placebo control condition consisting of weekly telephone contact</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="46"/>
                  <measurement group_id="O2" value="41"/>
                  <measurement group_id="O3" value="19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Social Phobia Remission Rate at 6 Month Follow-up</title>
            <description>Lack of SocialPhobia Diagnosis at 6 month follow-up</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                  <measurement group_id="O2" value="23"/>
                  <measurement group_id="O3" value="NA">Wait list was treated at the end of 12 weeks</measurement>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Social Effectiveness Therapy</title>
          <description>Social skills training and exposure therapy - each conducted once per week.</description>
        </group>
        <group group_id="E2">
          <title>Imaginal and In Vivo Exposure</title>
          <description>Exposure treatment - imaginal and in vivo exposure conducted twice per week</description>
        </group>
        <group group_id="E3">
          <title>Attention Placebo Control</title>
          <description>Placebo - attention placebo control condition consisting of weekly telephone contact</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Deborah C. Beidel, Ph.D.</name_or_title>
      <organization>University of Central Florida</organization>
      <phone>407-823-3254</phone>
      <email>deborah.beidel@ucf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
